Variation in precursor lesions of pancreatic cancer among high-risk groups

Clinical Cancer Research

Volumn 19, Issue 2, 2013, Pages 442-449

  Potjer, Thomas P ^a   Schot, Ingrid ^a   Langer, Peter ^c   Heverhagen, Johannes T ^c   Wasser, Martin N J M ^a   Slater, Emily P ^c   Klöppel, Günter ^d   Morreau, Hans M ^a   Bonsing, Bert A ^a   De Vos Tot Nederveen Cappel, Wouter H ^b   Bargello, Mathias ^c   Gress, Thomas M ^c   Vasen, Hans F A ^a   Bartsch, Detlef K ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ISALA HOSPITAL   (Netherlands)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16;

ADULT; AGED; ARTICLE; CANCER GROWTH; COHORT ANALYSIS; CONTROLLED STUDY; ENDOSCOPIC ECHOGRAPHY; FAMILIAL CANCER; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC VARIABILITY; GERM LINE; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LEIDEN GENE; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; P16 GENE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS CYST; PANCREAS SURGERY; PRIORITY JOURNAL; TUMOR GENE;

ADULT; AGED; CARCINOMA; CARCINOMA, PANCREATIC DUCTAL; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PANCREATIC NEOPLASMS; REGISTRIES;

EID: 84872519206     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-2730     Document Type: Article

References (32)

1. Jemal A, Bray F, CenterMM,Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61: 69-90.
2. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61: 212-36.
3. Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R, et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 2004;198: 722-31.
4. Hruban RH, Maitra A, Kern SE, Goggins M. Precursors to pancreatic cancer. Gastroenterol Clin North Am 2007;36: 831-49.
5. Sipos B, Frank S, Gress T, Hahn S, Klöppel G. Pancreatic intraepithelial neoplasia revisited and updated. Pancreatology 2008;9: 45-54.
6. Hemminki K, Li X. Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden. Int J Cancer 2003;103: 525-30.
7. Bartsch DK, Kress R, Sina-Frey M, Grützmann R, Gerdes B, Pilarsky C, et al. Prevalence of familial pancreatic cancer in Germany. Int J Cancer 2004;110: 902-6.
8. Shi C, Hruban RH, Klein AP. Familial pancreatic cancer. Arch Pathol Lab Med 2009;133: 365-74.
9. Vasen HF, Gruis NA, Frants RR, van der Velden PA, Hille ET, Bergman W. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanomaassociated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer 2000;87: 809-11.
10. Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJ, et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 2004;64: 2634-8.
11. Brentnall TA, Bronner MP, Byrd DR, Haggitt RC, Kimmey MB. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 1999;131: 247-55.
12. Kimmey MB, Bronner MP, Byrd DR, Brentnall TA. Screening and surveillance for hereditary pancreatic cancer. Gastrointest Endosc 2002;56:S82-6.
13. Canto MI, Goggins M, Yeo CJ, Griffin C, Axilbund JE, Brune K, et al. Screening for pancreatic neoplasia in high-risk individuals: an EUSbased approach. Clin Gastroenterol Hepatol 2004;2: 606-21.
14. Canto MI, Goggins M, Hruban RH, Petersen GM, Giardiello FM, Yeo C, et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 2006;4: 766-81.
15. Poley JW, Kluijt I, Gouma DJ, Harinck F, Wagner A, Aalfs C, et al. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am J Gastroenterol 2009;104: 2175-81.
16. Kluijt I, Cats A, Fockens P, Nio Y, Gouma DJ, Bruno MJ. Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance. J Clin Gastroenterol 2009;43: 853-7.
17. Langer P, Kann PH, Fendrich V, Habbe N, Schneider M, Sina M, et al. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer. Gut 2009;58: 1410-8.
18. Verna EC, Hwang C, Stevens PD, Rotterdam H, Stavropoulos SN, Sy CD, et al. Pancreatic cancer screening in a prospective cohort of highrisk patients: a comprehensive strategy of imaging and genetics. Clin Cancer Res 2010;16: 5028-37.
19. Ludwig E, Olson SH, Bayuga S, Simon J, Schattner MA, Gerdes H, et al. Feasibility and yield of screening in relatives from familial pancreatic cancer families. Am J Gastroenterol 2011;106: 946-54.
20. Al-Sukhni W, Borgida A, Rothenmund H, Holter S, Semotiuk K, Grant R, et al. Screening for pancreatic cancer in a high-risk cohort: an eightyear experience. J Gastrointest Surg 2012 Apr;16: 771-83.
21. Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z, et al. Frequent detection of pancreatic lesions in asymptomatic highrisk individuals. Gastroenterology 2012;142: 796-804.
22. Vasen HF, Wasser M, van Mil A, Tollenaar R, Konstantinovski M, Gruis NA, et al. Magnetic resonance imaging surveillance detects earlystage pancreatic cancer in carriers of a p16-Leiden mutation. Gastroenterology 2011;140: 850-6.
23. Irisawa A, Sato A, Sato M, Ikeda T, Suzuki R, Ohira H. Early diagnosis of small pancreatic cancer: role of endoscopic ultrasonography. Dig Endosc 2009;21 Suppl 1:S92-6.
24. Ku YM, Shin SS, Lee CH, Semelka RC. Magnetic resonance imaging of cystic and endocrine pancreatic neoplasms. Top Magn Reson Imaging 2009;20: 11-18.
25. Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004;28: 977-87.
26. Furukawa T, Klöppel G, Volkan Adsay N, Albores-Saavedra J, Fukushima N, Horii A, et al. Classification of types of intraductal papillarymucinous neoplasm of the pancreas: a consensus study. Virchows Arch 2005;447: 794-9.
27. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6: 17-32.
28. Aguirre AJ, Bardeesy N, Sinha M, Lopez L, Tuveson DA, Horner J, et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev 2003;17: 3112-26.
29. de Jong K, Nio CY, Hermans JJ, Dijkgraaf MG, Gouma DJ, van Eijck CH, et al. High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations. Clin Gastroenterol Hepatol 2010;8: 806-11.
30. Andea A, Sarkar F, Adsay VN. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod Pathol 2003;16: 996-1006.
31. Shi C, Klein AP, Goggins M, Maitra A, Canto M, Ali S, et al. Increased prevalence of precursor lesions in familial pancreatic cancer patients. Clin Cancer Res 2009;15: 7737-43.
32. Roggin KK, Chennat J, Oto A, Noffsinger A, Briggs A, Matthews JB. Pancreatic cystic neoplasm. Curr Probl Surg 2010;47: 459-510.